138 related articles for article (PubMed ID: 4734403)
1. The relationship of glycine-rich -glycoprotein to factor B in the properdin system and to the cobra factor-binding protein of huan serum.
Alper CA; Goodkofsky I; Lepow IH
J Exp Med; 1973 Feb; 137(2):424-37. PubMed ID: 4734403
[TBL] [Abstract][Full Text] [Related]
2. Studies on the properdin system: isolation of a heat-labile factor from guinea pig serum related to a human glycine rich beta-glycoprotein (GBG or factor B).
Brade V; Cook CT; Shin HS; Mayer MM
J Immunol; 1972 Dec; 109(6):1174-81. PubMed ID: 4628703
[No Abstract] [Full Text] [Related]
3. Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose.
Vogt W; Schmidt G; Dieminger L; Lynen R
Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(5):440-55. PubMed ID: 126576
[TBL] [Abstract][Full Text] [Related]
4. Formation and function of a complex of the C3 proactivator with a protein from cobra venom.
Cooper NR
J Exp Med; 1973 Feb; 137(2):451-60. PubMed ID: 4734404
[TBL] [Abstract][Full Text] [Related]
5. Inactivator of the third component of complement as an inhibitor in the properdin pathway.
Alper CA; Rosen FS; Lachmann PJ
Proc Natl Acad Sci U S A; 1972 Oct; 69(10):2910-3. PubMed ID: 4507613
[TBL] [Abstract][Full Text] [Related]
6. Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia.
Charlesworth JA; Williams DG; Sherington E; Lachmann PJ; Peters DK
J Clin Invest; 1974 Jun; 53(6):1578-87. PubMed ID: 4830223
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphism in human glycine-rich beta-glycoprotein.
Alper CA; Boenisch T; Watson L
J Exp Med; 1972 Jan; 135(1):68-80. PubMed ID: 4109808
[TBL] [Abstract][Full Text] [Related]
8. Cleavage of the third complement component (C3) and generation of the spasmogenic peptide, C3a, in human serum via the properdin pathway: demonstration of inhibitory as well as enhancing effects of epsilon-amino-caproic acid.
Vogt W; Schmidt G; Lynen R; Dieminger L
J Immunol; 1975 Feb; 114(2 Pt 1):671-7. PubMed ID: 804510
[TBL] [Abstract][Full Text] [Related]
9. The effect of anticomplementary substances on properdin in normal and C2-deficient sera.
McLean RH; Townsend K; Michael AF
Clin Exp Immunol; 1975 Mar; 19(3):435-44. PubMed ID: 1204244
[TBL] [Abstract][Full Text] [Related]
10. Purification and some properties of a heat labile serum factor (UP); identity with glycine-rich beta-glycoprotein and properdin factor B.
Lynen R; Brade V; Wolf A; Vogt W
Hoppe Seylers Z Physiol Chem; 1973 Jan; 354(1):37-47. PubMed ID: 4214745
[No Abstract] [Full Text] [Related]
11. Serum-dependent phagocytosis of paraffin oil emulsified with bacterial lipopolysaccharide.
Stossel TP; Alper CA; Rosen FS
J Exp Med; 1973 Mar; 137(3):690-705. PubMed ID: 4631990
[TBL] [Abstract][Full Text] [Related]
12. Complement in the serum and venom of Brazilian snakes (Crotalidae).
Dias da Silva W; Calich VL; Kipnis TL; Rosen FS; Alper CA
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():97-103. PubMed ID: 6587747
[TBL] [Abstract][Full Text] [Related]
13. Activation of the alternative (properdin) pathway by divalent cations.
Lew FT; Yukiyama Y; Waks HS; Osler AG
J Immunol; 1975 Sep; 115(3):884-8. PubMed ID: 807649
[TBL] [Abstract][Full Text] [Related]
14. Activation of the alternative pathway of complement in childhood acute lymphoblastic leukemia.
Kalwinsky DK; Urmson JR; Stitzel AE; Spitzer RE
J Lab Clin Med; 1976 Nov; 88(5):745-56. PubMed ID: 1068203
[TBL] [Abstract][Full Text] [Related]
15. Studies in vivo of cobra factor and murine C3.
Pepys MB
Immunology; 1975 Feb; 28(2):369-77. PubMed ID: 804439
[TBL] [Abstract][Full Text] [Related]
16. Nonimmune chemotaxis in vivo: inhibition by complement depletion with cobra factor.
Wiener S; Lendvai S; Rogers B; Urivetzky M; Meilman E
Am J Pathol; 1973 Dec; 73(3):807-16. PubMed ID: 4767264
[TBL] [Abstract][Full Text] [Related]
17. Immunological, structural and functional relationships between an anti-complementary protein from Crotalus atrox venom, cobra venom factor and human C3.
Minta JO; Man D
Immunology; 1980 Apr; 39(4):503-9. PubMed ID: 6769786
[TBL] [Abstract][Full Text] [Related]
18. The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.
Brade V; Lee GD; Nicholson A; Shin HS; Mayer MM
J Immunol; 1973 Nov; 111(5):1389-400. PubMed ID: 4795621
[No Abstract] [Full Text] [Related]
19. Association of activated properdin with complexes of properdin with C3.
Whiteman LY; Purkall DB; Ruddy S
J Immunol; 1991 Aug; 147(4):1344-51. PubMed ID: 1869827
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of anticomplementary and adjuvant properties of proteins derived from cobra venom.
Morrison DC; Louis JA; Weigle WO
Immunology; 1976 Mar; 30(3):317-23. PubMed ID: 56310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
